Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 095130100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Cormorant Asset Management, LP
13D
|
11.8% |
8/13/2026
Event 8/6/2026
|
|
| Cormorant Global Healthcare Master Fund, LP | 3.1% | ||
| Cormorant Global Healthcare GP, LLC | 3.1% | ||
| Cormorant Private Healthcare Fund III, LP | 4.0% | ||
| Cormorant Private Healthcare GP III, LLC | 4.0% | ||
| Cormorant Private Healthcare Fund V, LP | 3.4% | ||
| Cormorant Private Healthcare GP V, LLC | 3.4% | ||
| Cormorant Private Healthcare Fund VI, LP | 1.2% | ||
| Cormorant Private Healthcare GP VI, LLC | 1.2% | ||
| Cormorant Asset Management, LP | 11.8% | ||
| Chen Bihua | 11.8% | ||
|
Orbimed Advisors LLC
13D
|
8.9% |
8/18/2026
Event 8/10/2026
|
|
| Orbimed Advisors LLC | 8.9% | ||
| OrbiMed Capital GP VIII LLC | 8.9% | ||
|
Perceptive Advisors LLC
13G
|
5.9% |
8/14/2026
Event 8/7/2026
|
|
| Perceptive Advisors LLC | 5.9% | ||
| Joseph Edelman | 5.9% | ||
| Perceptive Life Sciences Master Fund, Ltd. | 5.9% | ||
|
Vivo Innovation Fund II Holdings, L.P.
13G
|
5.5% |
8/17/2026
Event 8/10/2026
|
|
| Vivo Innovation Fund II Holdings, L.P. | 5.5% | ||
| Vivo Innovation II, LLC | 5.5% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|